Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanobac Pharmaceuticals Announces Continuation of Space Act Agreement with NASA: NASA to Study Characterization of the Physical and Chemical Propertie

Abstract:
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or the "Company") is pleased to announce the signing of a Space Act Agreement with NASA's Johnson Space Center (JSC), Houston Texas, to collaborate on research on Calcifying Nanoparticles (CNP) and its nature and role in pathological calcification, including the detection and treatment of the pathogen. Since Astronauts may be more prone to an increased rate of pathological calcification while in a zero gravity environment, the collaboration will bring a new approach to NASA's need to better understand the effects of long-term space travel on humans.

Nanobac Pharmaceuticals Announces Continuation of Space Act Agreement with NASA: NASA to Study Characterization of the Physical and Chemical Propertie

TAMPA, FL | Posted on September 18th, 2007

NANOBAC and NASA are interested in pathological calcium phosphate particles found in diseases such as kidney stones, prostatitis, and arthritis, which are all conditions that accelerate in humans in a zero gravity environment. This collaboration would provide NASA the opportunity to utilize NANOBAC's diagnostic and treatment experience in this field in support of NASA's exploration goals related to understanding the effects of long-term space travel on humans and offer Nanobac the opportunity to further develop its methods and utilize NASA instrumentation to further characterize the CNPs.

Part of the instrumentation to be used is the Focused Ion Beam (FIB) in order to mill CNP samples for use in Scanning and Transmission Electron Microscopy (SEM, TEM, STEM) analyses to characterize internal CNP mineralogy. Additionally, Laser Microprobe, Organic Mass-Spectrometric analyses and Nano-SIMS elemental and isotopic analyses will be performed to characterize the organic content of the CNPs.

"We are pleased to be able to extend our Director of Science time at NASA for these important projects," commented Dr. Benedict Maniscalco, Nanobac's Co-Chair and Chief Medical Officer. "We appreciate the opportunity to work with some of the country's most talented scientists."

Nanobac's Director of Science Neva Ciftcioglu added: "The continuation of our collaborative research with NASA will give us an opportunity to stay with exceptionally experienced diverse scientific members helping us to complete the biological definition of the unique agent: calcifying nanoparticles."

####

About Nanobac Pharmaceuticals Inc.
Our objective is to develop methods to treat Calcifying Nanoparticles (CNPs), and by so doing find more effective approaches to the diseases associated with them.

Investors are cautioned that certain statements in this document, some statements in periodic press releases and some oral statements of Nanobac Pharmaceuticals, Inc. officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-Looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future Nanobac Pharmaceuticals, Inc. actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-Looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and Nanobac Pharmaceuticals, Inc. has no specific intention to update these statements.

For more information, please click here

Contacts:
Nanobac Pharmaceuticals, Tampa
Brady Millican
813-264-2241
or
Redwood Consultants
Jens Dalsgaard
415-884-0348

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

Announcements

An engineered surface unsticks sticky water droplets August 31st, 2015

New material science research may advance tech tools August 31st, 2015

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Aerospace/Space

An engineered surface unsticks sticky water droplets August 31st, 2015

National Space Society Welcomes Janet Ivey As New NSS Governor: Janet Ivey of Janet's Planet is NOW IN ORBIT as a member of the Board of Governors of the National Space Society August 27th, 2015

National Space Society Welcomes Geoff Notkin As New NSS Governor August 26th, 2015

A thin ribbon of flexible electronics can monitor health, infrastructure August 17th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic